Empirically Validated Treatments and AACBT

1997 ◽  
Vol 14 (1) ◽  
pp. 2-5 ◽  
Author(s):  
Neville J. King

Recently, the American Psychological Association (APA; 1993) Division of Clinical Psychologists (Division 12) established a task force to define empirically validated treatment and make recommendations in relation to methods for educating mental health professionals, third-party payors, and the public about effective psychotherapies. Predictably, the task force report has a somewhat controversial status but continues to be an influential blueprint for the improvement of clinical psychology in various countries including Australia. The role of the Australian Association for Cognitive and Behaviour Therapy (AACBT) is highlighted in relation to accreditation and mandatory professional development (Australian Psychological Society).

1997 ◽  
Vol 14 (4) ◽  
pp. 187-191 ◽  
Author(s):  
Timothy J. Sharp

Following on from the American Psychological Association's (1993) findings regarding empirically validated treatments, a British task force (Roth & Fonagy, 1996) arrived at similar conclusions. Both publications strongly endorsed the superior efficacy of cognitive-behaviour therapy (CBT) over placebos, waiting list controls and other psychological treatments. These findings, although not new, are becoming increasingly important as new ways of funding health care become more likely. With these probable changes in health system funding, organisations such as the Australian Association for Cognitive and Behaviour Therapy will almost certainly be asked to provide evidence supporting the efficacy of certain interventions for certain problems, but also to decide who can implement such treatments. This article attempts to present the well known findings within the current framework, and poses an important question: Who can ethically and competently practice CBT?


Author(s):  
Pierre Pestieau ◽  
Mathieu Lefebvre

This chapter reviews the public health care systems as well as their challenges. It first shows how expenditure on health care has evolved in previous decades and deals with the reasons for the growth observed in almost every European country. It emphasizes the role of technological progress as a main explanatory factor of the increase in medical expenditure but also points to the challenges facing cost-containment policies. Especially, the main common features of health care systems in Europe, such as third-party payment, single provider approach and cost-based reimbursement are discussed. Finally the chapter shows that although inequalities in health exist in the population, health care systems are redistributive. Reforms are thus needed but the trade-off between budgetary efficiency and equity is difficult.


Sign in / Sign up

Export Citation Format

Share Document